(Q40815265)

24 September 2017

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis (English)

1 reference

multicenter clinical trial

24 September 2017

0 references

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

ORCID Public Data File 2021

author name string

Begg AC

1

1 reference

24 September 2017

Haustermans K

2

1 reference

24 September 2017

Hart AA

3

1 reference

24 September 2017

Dische S

4

1 reference

24 September 2017

Saunders M

5

1 reference

24 September 2017

Zackrisson B

6

1 reference

24 September 2017

Gustaffson H

7

1 reference

24 September 2017

Coucke P

8

1 reference

24 September 2017

Paschoud N

9

1 reference

24 September 2017

Hoyer M

10

1 reference

24 September 2017

Overgaard J

11

1 reference

24 September 2017

Antognoni P

12

1 reference

24 September 2017

Richetti A

13

1 reference

24 September 2017

Bourhis J

14

1 reference

24 September 2017

Bartelink H

15

1 reference

24 September 2017

Horiot JC

16

1 reference

24 September 2017

Corvo R

17

1 reference

24 September 2017

Giaretti W

18

1 reference

24 September 2017

Awwad H

19

1 reference

24 September 2017

Shouman T

20

1 reference

24 September 2017

Jouffroy T

21

1 reference

24 September 2017

Maciorowski Z

22

1 reference

24 September 2017

Dobrowsky W

23

1 reference

24 September 2017

Struikmans H

24

1 reference

24 September 2017

Wilson GD

25

1 reference

24 September 2017

1 January 1999

1 reference

Radiotherapy and Oncology

24 September 2017

1 reference

24 September 2017

50

1 reference

24 September 2017

13-23

1 reference

24 September 2017

1

1 reference

Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Local control versus dose or overall time: from coefficients to percentages.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Loss of local control with prolongation in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

The effect of treatment duration in the local control of cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

In vivo cell kinetic measurements in human oesophageal cancer: what can be learned from multiple biopsies?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Proliferation characteristics of human colorectal carcinomas measured in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Interrelationships of DNA-ploidy and cell proliferation markers with T-stage and N-stage in primary laryngeal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

The predictive value of tumor-cell kinetic parameters in radiotherapy: considerations regarding data production and analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current Status

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900147-9

7 January 2021

10.1016/S0167-8140(98)00147-9

Identifiers

DOI

1 reference

24 September 2017

1 reference